Naomi Fujioka, MD

Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation

Naomi Fujioka

Contact Info

Office Address:
Division of Hematology, Oncology and Transplantation
420 Delaware Street SE
MMC 480
Minneapolis, MN 55455

Administrative Assistant Name
Pamela Hansen

Administrative Phone
612-625-9604

Administrative Email
hanse032@umn.edu

Administrative Fax Number
612-625-6919

Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation


Medical Oncologist


Medical School, University of Minnesota Medical School, Minneapolis, MN

Medicine Residency, University of Minnesota, Minneapolis, MN

Hematology/Oncology Fellowship, University of Minnesota, Minneapolis, MN

Summary

Dr. Fujioka is a Medical Oncologist specializing in thoracic and head/neck malignancies. Her research is focused on developing food-based chemoprevention against tobacco and environmental carcinogens, and collaborating to develop novel biomarkers of carcinogen-induced DNA damage. Dr. Fujioka also acts as site Principal Investigator for several cancer therapy clinical trials. She joined the faculty in 2011 after completing all of her training at the University of Minnesota.

Expertise

  • Thoracic malignancies
  • Head and neck malignancies
  • Lung cancer chemoprevention

Awards & Recognition

  • Minneapolis/St. Paul Magazine Top Doc 2018, 2019
  • Minnesota Monthly MagazineTop Doctors in Minnesota, 2019
  • International Association for the Study of Lung Cancer
  • American Society of Clinical Oncology
  • American Association for Cancer Research

Professional Associations

  • Co-Director, HOT Division 7D Clinical Services
  • Member, Thoracic Translational Working Group
  • Member, International Association for the Study of Lung Cancer
  • Member, American Society of Clinical Oncology
  • Member, American Association for Cancer Research

Research

Research Summary/Interests

  • Lung cancer chemoprevention
  • Phase I clinical trials
  • Tobacco carcinogens and carcinogenesis
  • Food-based chemoprevention of tobacco-related lung cancer

Publications

  • Fujioka N, Ainslee-Waldman CE, Upadhyaya P, Carmella SG, Fritz VA, Rohwer C, Fan Y, Rauch D, Le C, Hatsukami DK, Hecht SS. Urinary 3,3’-diindolylmethane: a biomarker of glucobrassicin exposure and indole-3-carbinol update in humans. Submitted for publication.
  • Hecht SS, Hochalter JB, Carmella SG, Zhang Y, Rauch DM, Fujioka N, Jensen N, Hatsukami DK. Longitudinal study of [D10]phenanthrene metabolism by the diol epoxide pathway in smokers. Biomarkers. 2013;18(2):144-50. PMID 23336104
  • Fujioka N, Bitterman PB. Molecular targeted therapy in lung cancer. Minn Med. 2012;95(10):38-41.
    PMID 23193704.
  • Fujioka N, Nguyen J, Chen C, Li Y, Pasrija T, Niehans G, Johnson KN, Gupta V, Kratzke RA, Gupta K. Morphine induced epidermal growth factor pathway activation in non-small-cell lung cancer. Anesth Analg. 2011; 113(6):1353-64. PMID 22003224.
  • Fujioka N, French CA, Cameron MJ, Kratzke RA. Long term survival of a patient with non-small-cell lung cancer harboring NUT gene rearrangement. J Thorac Oncol. 2010;5:1704-05. PMID 20871268.
  • Fujioka N, Dudek A, Kirstein MN, Kumar P. Phase I study of sorafenib, cisplatin, and pemetrexed for the treatment of advanced solid tumors (abstract). J Clin Oncol. 2010 (suppl; abstr e13055).
  • Stepanov I, Fujioka N. Bringing attention to e-cigarette pH as an important element for research and regulation. Tob Control. 2015 Jul;24(4):413-4. doi: 10.1136/tobaccocontrol-2014-051540. Epub 2014 May 14.
    Fujioka N, Ainslee-Waldman CE, Upadhyaya P, Carmella SG, Fritz VA, Rohwer C, Fan Y, Rauch D, Le C, Hatsukami DK, Hecht SS. Urinary 3,3’-diindolylmethane: a biomarker of glucobrassicin exposure and indole-3-carbinol update in humans. Cancer Epidemiol Biomarkers Prev. 2014;23(2):282-7. PMID 24357105.
  • Hecht SS, Hochalter JB, Carmella SG, Zhang Y, Rauch DM, Fujioka N, Jensen N, Hatsukami DK. Longitudinal study of [D10]phenanthrene metabolism by the diol epoxide pathway in smokers. Biomarkers. 2013;18(2):144-50. PMID 23336104.
  • Fujioka N, Nguyen J, Chen C, Li Y, Pasrija T, Niehans G, Johnson KN, Gupta V, Kratzke RA, Gupta K. Morphine induced epidermal growth factor pathway activation in non-small-cell lung cancer. Anesth Analg. 2011; 113(6):1353-64. PMID 220032
  • Fujioka N, French CA, Cameron MJ, Kratzke RA. Long term survival of a patient with non-small-cell lung cancer harboring NUT gene rearrangement. J Thorac Oncol. 2010;5:1704-05. PMID 20871268

Clinical

Specialties

  • Cancer
  • Medical Oncology

Clinics

Masonic Cancer Center

Board Certifications

  • Medical Oncology
  • Internal Medicine

Clinical Interests

Lung Cancer; Lung Cancer Chemoprevention; Head and Neck Cancer